A carregar...

The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A

BACKGROUND: Risk factors for the development of inhibitors in previously untreated patients (PUPs) have been reported; this is not the case in previously treated patients (PTPs) owing to fewer studies. Risk factors may differ for the development of PTP versus PUP inhibitors. We aimed to identify ris...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Res
Main Authors: Kim, Ju Young, You, Chur Woo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779946/
https://ncbi.nlm.nih.gov/pubmed/31730688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2019.54.3.204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!